Calumet (NASDAQ: CLMT) director sells 82,000 shares under 10b5-1 plan

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Calumet, Inc. director Daniel J. Sajkowski reported a series of open-market sales of common stock under a pre-arranged Rule 10b5-1 trading plan. Between March 3 and July 1, 2025, he sold a total of 82,000 shares of common stock in five transactions at reported weighted average prices ranging from $10.66 to $15.77 per share. After the most recent sale of 2,000 shares at $15.77 per share, his direct holdings stood at 82,237 shares of Calumet, Inc. common stock.

Insider Trade Summary

Net Seller: 82,000 shares ($1,038,340)

Net Sell 5 txns

Insider Sajkowski Daniel J

Role Director

Sold 82,000 shs ($1.04M)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share	2,000	$15.77	$32K
Sale	Common Stock, par value $0.01 per share	20,000	$13.40	$268K
Sale	Common Stock, par value $0.01 per share	20,000	$10.66	$213K
Sale	Common Stock, par value $0.01 per share	20,000	$12.55	$251K
Sale	Common Stock, par value $0.01 per share	20,000	$13.73	$275K

Holdings After Transaction: Common Stock, par value $0.01 per share — 82,237 shares (Direct)

Footnotes (1)

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.35 per share to $14.06 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.06 per share to $12.91 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.40 per share to $10.90 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.07 per share to $13.86 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.53 per share to $16.02 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.

Form 4 Insider Transactions: What Each Field Means →

02/26/2026 - 08:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sajkowski Daniel J

(Last)

(First)

(Middle)

1060 N CAPITOL AVE

SUITE 6-401

(Street)

INDIANAPOLIS

46204

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	03/03/2025		S⁽¹⁾		20,000	D	$13.73⁽²⁾	141,959	D
Common Stock, par value $0.01 per share	04/01/2025		S⁽¹⁾		20,000	D	$12.55⁽³⁾	121,959	D
Common Stock, par value $0.01 per share	05/01/2025		S⁽¹⁾		20,000	D	$10.66⁽⁴⁾	101,959	D
Common Stock, par value $0.01 per share	06/02/2025		S⁽¹⁾		20,000	D	$13.4⁽⁵⁾	81,959	D
Common Stock, par value $0.01 per share	07/01/2025		S⁽¹⁾		2,000	D	$15.77⁽⁶⁾	82,237	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.35 per share to $14.06 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.06 per share to $12.91 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.40 per share to $10.90 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.

5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.07 per share to $13.86 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.

6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.53 per share to $16.02 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.

	/s/ Connor J. Egan, as attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Calumet (CLMT) report for Daniel J. Sajkowski?

Calumet reported that director Daniel J. Sajkowski sold 82,000 shares of common stock in five open-market transactions. These sales occurred between March 3 and July 1, 2025, and were executed under a pre-established Rule 10b5-1 trading plan.

Over what dates did Sajkowski sell Calumet (CLMT) shares and in what amounts?

Sajkowski sold Calumet shares on March 3, April 1, May 1, June 2, and July 1, 2025. The transactions were for 20,000 shares on four of those dates and 2,000 shares on July 1, totaling 82,000 shares sold.

At what prices were the Calumet (CLMT) insider sales by Sajkowski executed?

The reported weighted average sale prices ranged from $10.66 to $15.77 per share. Footnotes explain that each transaction involved multiple trades within price ranges, with detailed breakdowns available upon request from Calumet, Inc. or the Securities and Exchange Commission staff.

How many Calumet (CLMT) shares does Daniel J. Sajkowski hold after these sales?

After the latest reported sale on July 1, 2025, Sajkowski directly owned 82,237 shares of Calumet, Inc. common stock. This figure reflects his holdings immediately following the 2,000-share open-market sale at a weighted average price of $15.77 per share.

Were the Calumet (CLMT) insider sales by Sajkowski under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected under a Rule 10b5-1 trading plan adopted on March 14, 2024. Such plans pre-schedule trades, allowing insiders to sell shares over time according to predetermined instructions and timing.